19 October 2026
A study published in Nature Cell Biology reveals how ADAR1 and FTSJ1 regulate mistranslation in cancer cells under tryptophan-limiting conditions. IMMAGINA Biotechnology contributed nano-tRNA sequencing expertise to investigate the role of tRNA modificati
15 October 2026
Having more mRNA does not always mean producing more protein. Understanding how efficiently an mRNA is translated can help researchers improve therapeutic design. Explore the factors influencing translation efficiency and how ribosome profiling provides i
13 October 2026
How can complementary RNA technologies help researchers address complex questions in cancer biology? Watch our European RNA Alliance (ERA) webinar to explore how integrated approaches to RNA analysis, functional genomics, and translatomics can provide dee
5 October 2026
Join ERA’s first webinar on 12 October to explore how European RNA companies can support cancer research through complementary technologies, practical examples and a live panel Q&A.
30 September 2026
October takes the Immagina team across Germany, Italy, and the US for a new series of RNA-focused conferences and scientific meetings. See where you can meet us this month.
15 September 2026
Immagina BioTechnology is featured in a Nature Biotechnology article highlighting the growing interest in the dark proteome and the technologies helping researchers uncover previously overlooked proteins.
